Americas research labs are quietly bleeding international talent

On this year's Match Day, the rate at which international medical graduates who need visas secured positions in U.S. residency programs fell to a five-year low — the concrete, measurable consequence of an immigration crackdown that researchers say is already reshaping the scientific talent pipeline.

The five-year low, reported Monday by STAT News, is the sharpest single data point in a broader pattern: survey data published this week showing that 14 percent of NIH-funded labs have lost scientist or postdoc offers and 13 percent have lost researchers to other countries because of immigration policy changes. In the same survey, conducted Jan. 28 through Feb. 18, two-thirds of researchers said they had counseled students to consider careers outside the ivory tower, and 53 percent were specifically advising students to consider positions outside the U.S. — numbers that predate the most recent immigration actions but are now being amplified by them.

"We're seeing fewer applications from international students, and the ones already here are afraid to travel to conferences abroad or even go home for holidays because they might not get back in," said Matthew Alexander, an associate professor of pediatric neurology and genetics at the University of Alabama at Birmingham. "It's going to cause a long-term brain drain — international scholars will stay closer to home. There are good institutions in Europe and Asia now."

The policy shifts have been concrete. The Trump administration announced in September that employers would owe an additional $100,000 fee for each new H-1B visa sponsored for foreign workers entering the U.S., citing abuse in the program. Medical groups including the American Medical Association have asked the Department of Homeland Security to exempt physicians and researchers, arguing they help address domestic shortages and often work in underserved communities. Whether those exemptions will materialize remains unclear.

"We are facing challenges at all phases of the game," said Jenny Bouta Mojica, an immigration attorney who works with academic institutions. "Visas are taking longer to schedule, officials are requiring more documentation, and it's creating a climate where labs are becoming reluctant to sponsor people who need them."

The story plays out in individual choices. One Indian Ph.D. student, set to finish her doctorate this summer with a postdoc lined up in America, will instead return to India to work at a biotech company. A required public disclosure of her social media profiles during a visa renewal kept her out of the lab for two critical months — and the friction made the postdoc no longer worth it. Her lab leader verified her account. "This process is just not worth it for me," she told STAT News.

Eyas Mohammedalamin, a Sudanese medical school graduate who did not match into a U.S. residency program after studying in Egypt — Sudan is on the travel ban list — said residency directors asked during interviews whether he held dual citizenship or other means of entry. He thinks his country of origin factored into why he received no matches.

"You don't stop just because one country stops you from reaching that level," he said. He is now exploring options in Egypt, South Africa, and Australia, or a return to Sudan.

International medical graduates already in the country on student visas have begun questioning whether they will be allowed to transition onto work authorization — known as OPT, for optional practical training — if they are from countries on the travel ban list, researchers said.

The effects extend beyond immigration. In a separate STAT News survey of the same NIH-funded researcher population published in March, more than a quarter of respondents had laid off lab members, and more than two out of five had canceled planned research. The immigration findings are distinct from — but compounding — the disruption already caused by NIH funding pauses and grant uncertainty.

Researchers who asked to remain anonymous described a climate of fear — some said their institutions had told them not to speak publicly, others worried about drawing attention from federal officials at a moment when grant funding was already uncertain. One described international trainees leaving to return home or take positions in other countries. "Their lives are becoming somewhat dystopian, and I feel so ashamed and bad for them," the researcher said.

"I just don't know how this plays out," said Brendan Delaney, an immigration attorney. "Is that going to be nonprofit research organizations? Is it going to be biomedical?"

Alexander said the effects will outlast any individual administration. "This is infrastructure," he said. "You can't just rebuild a generation of scientists once they've gone elsewhere."